Intestinal Cholecystokinin Controls Glucose Production through a Neuronal Network

Cell Metabolism

Volumn 10, Issue 2, 2009, Pages 99-109

  Cheung, Grace W C ^a,b   Kokorovic, Andrea ^a,b   Lam, Carol K L ^a,b   Chari, Madhu ^a,b   Lam, Tony K T ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTESTINE; LIPID DIET; LIVER; MALE; NERVE CELL NETWORK; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLECYSTOKININ; DEVAZEPIDE; DIETARY FATS; DUODENUM; GLUCOSE; INSULIN; INSULIN RESISTANCE; MALE; NERVE NET; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A;

EID: 67849124833     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.07.005     Document Type: Article

References (43)

1. Badman M.K., and Flier J.S. The gut and energy balance: visceral allies in the obesity wars. Science 307 (2005) 1909-1914
2. Berthoud H.R., and Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat. (Basel) 156 (1996) 123-131
3. Bi S., Ladenheim E.E., Schwartz G.J., and Moran T.H. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R254-R260
4. Blumberg S., Haba D., Schroeder M., Smith G.P., and Weller A. Independent ingestion and microstructure of feeding patterns in infant rats lacking CCK-1 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R208-R218
5. Caspi L., Wang P.Y., and Lam T.K. A balance of lipid-sensing mechanisms in the brain and liver. Cell Metab. 6 (2007) 99-104
6. Chandra R., and Liddle R.A. Cholecystokinin. Curr. Opin. Endocrinol. Diabetes Obes. 14 (2007) 63-67
7. Coll A.P., Farooqi I.S., and O'Rahilly S. The hormonal control of food intake. Cell 129 (2007) 251-262
8. Corp E.S., McQuade J., Moran T.H., and Smith G.P. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res. 623 (1993) 161-166
9. Cummings D.E., and Overduin J. Gastrointestinal regulation of food intake. J. Clin. Invest. 117 (2007) 13-23
10. Drucker D.J. The biology of incretin hormones. Cell Metab. 3 (2006) 153-165
11. Duran-Sandoval D., Cariou B., Percevault F., Hennuyer N., Grefhorst A., van Dijk T.H., Gonzalez F.J., Fruchart J.C., Kuipers F., and Staels B. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J. Biol. Chem. 280 (2005) 29971-29979
12. Funakoshi A., Miyasaka K., Shinozaki H., Masuda M., Kawanami T., Takata Y., and Kono A. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 210 (1995) 787-796
13. Gulley S., Sharma S.K., Mansour M., Sullivan C.N., Moran T.H., and Sayegh A.I. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation. Brain Res. 1058 (2005) 109-119
14. Holst J.J. The physiology of glucagon-like peptide 1. Physiol. Rev. 87 (2007) 1409-1439
15. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
16. Kievit P., Howard J.K., Badman M.K., Balthasar N., Coppari R., Mori H., Lee C.E., Elmquist J.K., Yoshimura A., and Flier J.S. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 4 (2006) 123-132
17. Kim S.J., Nian C., Doudet D.J., and McIntosh C.H. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes 57 (2008) 1331-1339
18. Lam T.K., Pocai A., Gutierrez-Juarez R., Obici S., Bryan J., Aguilar-Bryan L., Schwartz G.J., and Rossetti L. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11 (2005) 320-327
19. Lam T.K., Gutierrez-Juarez R., Pocai A., Bhanot S., Tso P., Schwartz G.J., and Rossetti L. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13 (2007) 171-180
20. Liddle R.A., Rushakoff R.J., Morita E.T., Beccaria L., Carter J.D., and Goldfine I.D. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans. J. Clin. Invest. 81 (1988) 1675-1681
21. Lieverse R.J., Jansen J.B., Masclee A.A., Rovati L.C., and Lamers C.B. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 35 (1994) 501-505
22. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., D'Amato M., Rovati L., and Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46 (2000) 688-693
23. Melville L.D., Smith G.P., and Gibbs J. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats. Pharmacol. Biochem. Behav. 43 (1992) 975-977
24. Metzger B.L., and Hansen B.C. Cholecystokinin effects on feeding, glucose, and pancreatic hormones in rhesus monkeys. Physiol. Behav. 30 (1983) 509-518
25. Moran T.H. Unraveling the obesity of OLETF rats. Physiol. Behav. 94 (2008) 71-78
26. Moran T.H., and Kinzig K.P. Gastrointestinal satiety signals II. Cholecystokinin. Am. J. Physiol Gastrointest. Liver Physiol. 286 (2004) G183-G188
27. Moran T.H., Smith G.P., Hostetler A.M., and McHugh P.R. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res. 415 (1987) 149-152
28. Moran T.H., Norgren R., Crosby R.J., and McHugh P.R. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res. 526 (1990) 95-102
29. Morisset J., Julien S., and Laine J. Localization of cholecystokinin receptor subtypes in the endocine pancreas. J. Histochem. Cytochem. 51 (2003) 1501-1513
30. Murphy K.G., and Bloom S.R. Gut hormones and the regulation of energy homeostasis. Nature 444 (2006) 854-859
31. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781
32. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8 (2002) 1376-1382
33. Rasmussen H., Zawalich K.C., Ganesan S., Calle R., and Zawalich W.S. Physiology and pathophysiology of insulin secretion. Diabetes Care 13 (1990) 655-666
34. Ritter R.C., and Ladenheim E.E. Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am. J. Physiol. 248 (1985) R501-R504
35. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 31 Suppl 2 (2008) S290-S296
36. Rushakoff R.J., Goldfine I.D., Carter J.D., and Liddle R.A. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. J. Clin. Endocrinol. Metab. 65 (1987) 395-401
37. Saito A., Sankaran H., Goldfine I.D., and Williams J.A. Cholecystokinin receptors in the brain: characterization and distribution. Science 208 (1980) 1155-1156
38. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
39. Schwartz G.J., Whitney A., Skoglund C., Castonguay T.W., and Moran T.H. Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am. J. Physiol. 277 (1999) R1144-R1151
40. Shiba Y., Yamasaki Y., Kubota M., Matsuhisa M., Tomita T., Nakahara I., Morishima T., Kawamori R., and Hori M. Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model. Metabolism 47 (1998) 908-914
41. Verspohl E.J., Zoll C., Wahl M.A., and Ammon H.P. The role of cholecystokinin (CCK8) on glucose production and elimination, and on plasma insulin and glucose in rats. Peptides 13 (1992) 1091-1095
42. Wang P.Y., Caspi L., Lam C.K., Chari M., Li X., Light P.E., Gutierrez-Juarez R., Ang M., Schwartz G.J., and Lam T.K. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452 (2008) 1012-1016
43. Zabielski R., Onaga T., Mineo H., Kato S., and Pierzynowski S.G. Intraduodenal cholecystokinin octapeptide (CCK-8) can stimulate pancreatic secretion in the calf. Int. J. Pancreatol. 17 (1995) 271-278